The species Staphylococcus argenteus was separated recently from Staphylococcus aureus (Tong S.Y., F. Schaumburg, M.J. Ellington, J. Corander, B. Pichon, F. Leendertz, S.D. Bentley, J. Parkhill, D.C. Holt, G. Peters, and P.M. Giffard, 2015) . The objective of this work was to characterise the genome of a non-human S. argenteus strain, which had been isolated from the faeces of a wild-living western lowland gorilla in Gabon, and analyse the spectrum of this species in matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). The full genome sequence revealed a scarcity of virulence genes and absence of resistance genes, indicating a decreased virulence potential compared to S. aureus and the human methicillin-resistant S. argenteus isolate MSHR1132 T . Spectra obtained by MALDI-TOF MS and the analysis of available sequences in the genome databases identified several MALDI-TOF MS signals that clearly differentiate S. argenteus, the closely related Staphylococcus schweitzeri and S. aureus. In conclusion, in the absence of biochemical tests that identify the three species, mass spectrometry should be employed as method of choice.
Differentiation of Staphylococcus argenteus (formerly: Staphylococcus aureus clonal complex 75) by mass spectrometry from S. aureus using the first strain isolated from a wild African great ape (Holt et al., 2011; Ruimy et al., 2009 Ruimy et al., , 2010 Schaumburg et al., 2012; Tong et al., 2015) . The S. argenteus strains that served for the species definition were collected from human hosts in Australia, Fiji and the United Kingdom, while the S. schweitzeri strains were isolated from African mammals, especially non-human primates and bats in Gabon and Côte d'Ivoire (Tong et al., 2015) . The distribution of S. argenteus is still unclear, since it is not possible to detect the species by conventional biochemical testing or 16S rRNA sequencing and its members would have been identified as S. aureus clonal complex (CC) 75, before the new species was defined by Tong et al. (2015) .
Here we describe two African S. argenteus isolates that originated from a faeces sample of a western lowland gorilla (Gorilla gorilla ssp. gorilla) and bushmeat of the same gorilla species. These strains were first identified as S. aureus by conventional testing and 16S rRNA sequencing and raised our interest because they http://dx.doi.org/10.1016/j.ijmm.2016.11.003 1438-4221/© 2016 Elsevier GmbH. All rights reserved.
were not typable using the S. aureus MLST (Multi Locus Sequence Type) and spa primer sets and their very unusual spectrum in matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) . The signals in the MALDI-TOF mass spectrum of S. aureus correlate to the masses of small ribosomal proteins, stress proteins and toxins with a molecular mass lower than 15 kDa. Most of the peptides that constitute these spectra have recently been identified in our laboratory (Josten et al., 2013) . Usually, the spectra of two different S. aureus clonal complexes deviate only by one, two or three peak shifts from each other. These peak shifts are caused by amino acid exchanges in the correlating peptides and can be confirmed by sequencing of their genes (Josten et al., 2013) . In contrast, the two ape isolates were characterised by at least eight peak shifts when compared to S. aureus strains. Analysis of the peak shifts indicated that the isolates might belong to the closely related new species S. argenteus. Interestingly, the virulence of S. argenteus is currently discussed controversially. Whereas some publications reported a decreased virulence compared to S. aureus (Chantratita et al., 2016; Tong et al., 2010 Tong et al., , 2013 , another paper described serious invasive infections and treatment failure (Thaipadungpanit et al., 2015) . In addition, there is nearly no information about animal isolates of this species. In order to resolve all of these issues, the genome of one of the strains was sequenced. The analysis of the peptides that constitute the MALDI profile confirmed the amino acid exchanges that corresponded to the peak shifts. In addition, the analysis of resistance and virulence genes of the gorilla isolate showed that it contained no resistance genes and even less virulence factors than the previously characterised strain S. argenteus MSHR1132 T which is methicillin-resistant and was isolated from a blood culture of an indigenous woman suffering from necrotizing fasciitis in Darwin, Australia (Holt et al., 2011) .
Materials and methods

Bacterial strains
Strain BN75 was isolated during a screening of faecal samples of wild-living apes for S. aureus. The samples were collected under direct observation in 2012 in a virgin forest area (Ivindo National Park) in east-central Gabon, transferred into a sterile tube and stored at −80 • C until further analysis. The host species was confirmed using mitochondrial DNA identification techniques. The differentiation between gorillas and chimpanzees is possible due to a deletion in the D loop (Santiago et al., 2002; van der Kuyl et al., 2000) . In order to avoid any contamination from the forest floor, samples were obtained from the core of the faeces and were tested for the presence of staphylococci using chromogenic media as previously described (Nagel et al., 2013; Wendt et al., 2010) . The second isolate, strain BN56 was obtained from a bush meat sample of a gorilla. The CC398 S. aureus isolate that was used for comparison in Fig. 1 was isolated from the nose of a piglet in Germany and typed at our institute.
Strain characterisation
Species identification of bacterial samples was confirmed by standard slide tests for the clumping factor and the 4-24 h tube test for free coagulase in rabbit-citrate-plasma (Becton and Dickinson; Heidelberg, Germany). S. aureus ATCC 33592 (MRSA; American Type Culture Collection, Wesel, Germany) and S. epidermidis DSM 20044 (German Collection of Microorganisms and cell cultures, Braunschweig, Germany) served as positive and negative controls. 16S rRNA amplification was performed as previously described (Herzner et al., 2011) . Both isolates were discriminated by spatyping (Koreen et al., 2004) using primers adapted to the sequence (Table 1) . Spa-types were determined using the StaphType software and the Ridom SpaServer (www. spaserver.ridom.de). For MLST typing the primers for aroE and yqiI were adapted to the sequence of S. argenteus MSHR1132 T as well (Table 1 ) and the DNA sequence analyses were performed employing the S. aureus MLST site (http://saureus.mlst.net/ ). MLST-1.8 (https://cge.cbs.dtu.dk/services/MLST/) was used for genomic data. Antibiotic susceptibility was tested by agar diffusion, employing disks loaded with penicillin, ampicillin, oxacillin, cefoxitin, cefazolin, gentamicin, netilmicin, erythromycin, clindamycin, imipenem, ciprofloxacin, fusidic acid, doxycycline, fosfomycin, vancomycin, teicoplanin, mupirocin, moxifloxacin, linezolid and rifampicin. Routine mass spectrometry was performed on a VITEK MS mass spectrometer (BioMérieux, Marcy l'Etoile, France) equipped with the Myla software as described (Josten et al., 2014) . Preparation of extracts or smeared samples and MALDI-TOF MS for typing were performed on a Bruker Biflex III (Bruker Daltonik GmbH, Bremen, Germany) with cell extracts in the linear positive mode as previously described (Josten et al., 2013 (Josten et al., , 2014 . Data was analysed using the flexAnalysis software (Bruker Daltonik GmbH, Bremen, Germany).
Sequencing
Sequencing of PCR products (spa, 16S rRNA, MLST) was performed by Seqlab (Göttingen, Germany) or Sequiserve (Vaterstetten, Germany). Genomic DNA of S. argenteus BN75 was prepared employing the Masterpure Gram-Positive DNA Purification Kit (Epicentre Biotechnologies, Madison, WI, USA). The genome was fully sequenced using the Illumina V3 kit and a MiSeq Sequencing System (Illumina Inc., San Diego, USA). The reads were assembled de novo by Spades version 3.5.0 and Abacas version 1.3.1. Gaps were closed employing PCR (for primer sequences see Table 1 ) and Sanger sequencing.
Data analysis
The genomic data were analysed using the following online tools: NCBI/BLAST (Altschul et al., 1990) , Phast (http:// phaster.ca/) (Arndt et al., 2016) , antiSMASH (http://antismash. secondarymetabolites.org) (Weber et al., 2015) , VirulenceFinder (https://cge.cbs.dtu.dk/services/VirulenceFinder/) and ResFinder (https://cge.cbs.dtu.dk//services/ResFinder/) (Kleinheinz et al., 2014) , CRISPRfinder (http://crispr.u-psud.fr/Server/CRIPRfinder. php) (Grissa et al., 2007) , Prodigal (http://prodigal.ornl.gov/) (Hyatt et al., 2010) , ANI (average nucleotide identity) calculator (http:// enve-omics.ce.gatech.edu/ani/) (Goris et al., 2007) , Protparam (http://web.expasy.org/protparam/), EMBOSS Seqret (http:// www.ebi.ac.uk/Tools/sfc/emboss seqret/), Translate Nucleic Acid Sequence Tool (http://biotools.umassmed.edu/cgi-bin/biobin/ transeq), Geneious (www.geneious.com) and Mauve (http:// darlinglab.org/mauve/) (Darling et al., 2010) .
Accession numbers
The genomes of S. argenteus and S. schweitzeri that were used for calculation of the peptide molecular weights are available at the EMBL Nucleotide Archive (S. argenteus: ERS140248, ERS140026, ERS140254, ERS140095, ERS154949, FR821777; S. schweitzeri: ERS140147, ERS140266, ERS140239, ERS140159, ERS140162, ERS140167, PRJNA321471, PRJNA321471 (Tong et al., 2015) ). The genome of S. argenteus MSHR1132 T is accessible in NCBI under accession numbers NC 016941.1 and FR821778.1. The genome of S. argenteus BN75 was submitted to Genbank under accession number CP015758.
Results
Detection by MALDI-TOF MS
Strains BN75 and BN56 were isolated during a typing project involving African ape isolates and at first identified as S. aureus by conventional biochemical and clinical tests (including 16S rRNA sequencing). Indeed, using the VITEK MS mass spectrometer (BioMérieux, Marcy l'Etoile, France) equipped with the Myla software and smeared samples, strain identification of strain BN75 either failed or the strain was identified as S. aureus. When typing was attempted, the spa and the MLST primers for aroE and yqiI designed for S. aureus did not amplify any products as described earlier for strains of the CC75 lineage (Monecke et al., 2010; MALDI-TOF mass spectrum of S. argenteus compared to the spectrum of S. aureus (CC398). The spectrum shows numerous peak shifts which are presented in detail in Table 2 . For this figure, a spot containing smeared cells and a spot containing cell extract were combined into a single measurement. Thus, the figure shows all signals, the peptides that are mainly excreted and present on the cell surface as well as the intracellular peptides which are observed with a higher intensity in cell extracts. PSM␣1 (m/z 2288) and PSM␣3 (m/z 2635) have been marked.
Table 2
Isoforms of peptides leading to peak shifts that distinguish the MALDI-TOF mass spectrometry profiles of S. aureus vs. S. argenteus and S. schweitzeri. Amino acid exchanges are bold and underlined. For better orientation, three additional invariant peptides (RpmJ, RpmC and Hup) and the two PSMs marked in Fig. 1 et al., 2009). After visual inspection, the mass spectrometry profiles of the extracts were rather unusual, as they deviated in several peaks from the typical S. aureus profile. Fig. 1 shows the characteristic mass profiles of an S. argenteus strain in comparison to an S. aureus isolate (CC398) and Table 2 compares the calculated masses and sequences of the peptides encoded in the genomes of S. argenteus to those of S. aureus. The comparison includes strain BN75 and all strains of S. schweitzeri which had been deposited in GenBank in Jan. 2016. The comparison showed that many mass shifts are shared between S. argenteus and S. schweitzeri, but the combination of shift of the SAR1012 signal to m/z 4429 and the shift of the delta toxin peak to m/z 3037 is characteristic for S. argenteus. In contrast, S. schweitzeri strains are distinguished by the SAR1012 mass signals at m/z 4525 or m/z 4503. For both new species, the peak shift of SAS049 from m/z 5525 to m/z 5823 seems to be characteristic (Table 2) .
Genome sequence of S. argenteus BN75
The genome-wide average nucleotide identities for strain BN75 and members of all three species were estimated employing the average nucleotide identity (ANI). Within a species, ANI values are usually higher than 95% (Goris et al., 2007) . The results showed an average nucleotide identity of 99.11% between strain BN75 and strain S. argenteus MSHR1132 T , of 92.17% between isolate BN75 and S. schweitzeri FSA084 T and only 87.14% between strain BN75 and S. aureus N315, confirming that strain BN75 is indeed a member of the species S. argenteus. Correspondingly, the white colour after growth on Columbia blood agar and a protein BLAST search employing the staphyloxanthin biosynthesis genes of S. aureus MRSA252 (SAR2642, SAR2643, SAR2645, SAR2646 and SAR2647), demonstrated that strain BN75 does not contain the staphyloxanthin biosynthesis gene cluster. The spa-type t7462 (repeat sequence: 259-23-23-17-17-17-23-23-23-17-16 ) and the MLST type ST2198 were determined by PCR with primers adjusted to the sequence of S. argenteus MSHR1132 T (Table 1) , and confirmed by the genome sequence data. Strain BN56 possessed spa type t7462 as well. The sequences of the primer binding regions of the nuclease gene of strain BN75 were identical to those of S. argenteus strains from Australia (Tong et al., 2015) , indicating that the S. aureus thermonuclease PCR (Brakstad et al., 1992) would yield positive results for this strain.
Virulence and resistance characteristics including production of secondary metabolites
In order to estimate the potential virulence of the strain, the genome and the MALDI-TOF MS profiles were analysed for the presence of virulence and resistance markers. The strain was fully sensitive to all antibiotics tested and there were no antibiotic resistance markers, indicating that strain BN75 has not yet been exposed to the selective pressure of antibiotic therapy. In contrast to strain MSHR1132 T , which contains a type IV SCCmec cassette and CRISPR/Cas sequences inserted into orfX (Holt et al., 2011) , a 6 kb fragment harbouring a restriction modification system and hypothetical proteins is inserted into orfX (rlmH). Furthermore, the CRISPR/Cas system of S. argenteus MSHR1132 T is not present in strain BN75 (Fig. 2A) . This indicates that the insertion of SCCmec and the CRISPR/Cas system might be a recent event in the history of strain MSHR1132 T . In correspondence with the lack of phage immunity, the genome harbours two complete phages including a phage with similarity to phiNM3 inserted into the hlb gene and containing the immune evasion factor genes scn, sak and chp but no enterotoxin genes. The second phage resembled phiETA3 but did not encode the exfoliative toxin gene.
A screen for virulence factors and colonization factors showed the presence of a capsule gene cluster with sequence similarity to type 8, sortase (srtA), two genes involved in lowering the negative charge of the cell envelope (mprF and dltA) and the biofilm (ica) gene cluster. S. argenteus BN75 contains the genomic island alpha ( SA␣) of about 25 kb, like strain MSHR1132 T (Holt et al., 2011) and S. aureus. The island encodes four proteins with similarity to exotoxins, one superantigen-like protein, a restriction modification system (hsdS and hsdM) and eleven lipoproteins. The alpha phenol soluble modulins (PSMs) are encoded in the vicinity and PSM␣1 (m/z 2288), PSM␣2 (m/z 2306), PSM␣3 (m/z 2635) and PSM␣4 (m/z 2228) were visible in the MALDI-TOF MS profiles of both strains (data not shown), demonstrating that these small cytolytic toxins are produced. This was also true for the delta toxin (m/z 3036) and indicated that the type IV agr system of S. argenteus BN75 is active (Chatterjee et al., 2011) . A part of the genomic island beta ( SA␤) is also present as shown by copies of hsdS and hsdM, however, compared to strain MSHR1132 T and modern S. aureus isolates, the characteristic toxin genes are missing and only the C-terminus of lukD is preceded by a ribosome binding site (Fig. 2B) . The bsa bacteriocin biosynthetic gene cluster, which is encoded in many S. aureus strains, is not present. The genomic island gamma ( SA␥) harbours three proteins with similarity to exotoxins, the alpha-toxin and the beta PSMs. The ess and esx type VII secretion system is also present but not complete, i. e., in contrast to strain MSHR1132 T (Holt et al., 2011) , strain BN75 does not harbour the genes esxC (esaC), esxB, esaE and essD (Fig. 2C) .
Apart from this, pathogenicity islands or acquired toxins with clinical significance (exfoliative toxin A and B, enterotoxin A-D, PVL toxin, toxic shock toxin, the streptolysin biosynthesis gene sagD) or plasmid sequences were not identified. Regarding the biosynthesis of secondary products, the aureusimine biosynthetic gene cluster, that is found in S. aureus, S. epidermidis and S. capitis, is present (Zimmermann and Fischbach, 2010) as well as the biosynthetic genes for a siderophore.
Discussion
The results show that in the absence of biochemical tests that definitively discriminate all strains of the novel lineages from S. aureus (Tong et al., 2015) , MALDI TOF MS appears to be the most convenient method to identify the three species in the clinical laboratory. Alternatively, the species can be detected by MLST typing which involves sequencing of seven PCR products or pulsed field gel electrophoresis (Chantratita et al., 2016) or a combination of spa typing and rpoB sequencing (Argudin et al., 2016) , which, however, are not performed in clinical routine diagnostics. PCR amplification of the thermonuclease gene (Brakstad et al., 1992) can also be used to distinguish S. schweitzeri from S. aureus and S. argenteus; due to a mismatch near the 3 in the reverse primer, no product is obtained when S. schweitzeri DNA is employed as template (Schaumburg et al., 2014; Tong et al., 2015) . In contrast to S. schweitzeri, S. argenteus is not able to synthesize the yellow pigment staphyloxanthin. However, about 10% of all clinical S. aureus isolates have only low or no activity of sigma factor B and produce little or no pigment on blood agar plates (Josten et al., 2013) and, therefore, colony colour cannot be used as a discriminating marker.
The genome analysis showed that S. argenteus BN75 harbours even less virulence and antibiotic resistance genes than S. argenteus MSHR1132 T and, in view of its origin, might represent a primal member of this species that did not exchange genes with currently circulating S. aureus strains. So far, most members of the species S. argenteus as judged by MLST (former designation "S. aureus CC75") were isolated in Australia (Monecke et al., 2010 (Monecke et al., , 2011 . Apart from Australia, further strains of CC75 (ST1223) have been reported from remote locations in South East Asia (Cambo- dia and Thailand), from South America (French Guiana), Fiji and also from Europe (Argudin et al., 2016; Chantratita et al., 2016; Monecke et al., 2010; Ruimy et al., 2009 Ruimy et al., , 2010 . It was speculated that the geographical localization of these strains in South East Asia might correlate with the relative proximity of Australia, while their presence in South America (French Guiana) was hypothesized to originate from the movement of the first settlers from Australia to South America (Holt et al., 2011) . In contrast, the first strains of S. schweitzeri were isolated from African apes and monkeys (Gabon, Ivory Coast) Tong et al., 2015) , bats (Akobi et al., 2012 ) and a human ST1822 S. schweitzeri isolate has also been reported (Ateba et al., 2012) . As the two S. argenteus strains described here were isolated from African great apes and another ST related to CC75 (ST2470) was reported from a straw-coloured fruit bat (Eidolon helvum) in Nigeria (Akobi et al., 2012) , S. argenteus does not only seem to be present in Australia, South America and South East Asia but also in African mammals.
The virulence potential of S. argenteus is interesting and so far, conflicting results have been published. Actually, communityacquired Australian S. argenteus isolates with and without SCCmec type IV have been isolated primarily from skin infections (McDonald et al., 2006; Tong et al., 2010) , and seemed less likely to be involved in sepsis (Tong et al., 2010) and showed reduced virulence in mice (Tong et al., 2013) , although two severe infections with strains that had acquired PVL toxin have been described in France (Dupieux et al., 2015) . A recent study from Thailand showed that as much as 19% of community-onset invasive sepsis cases in Thailand were infected with this species. However, there was significantly less respiratory failure associated with the infections and a similar, however statistically insignificant, trend was found for septic shock. The authors concluded that these effects might correlate with the scarcity of antimicrobial resistance and toxin genes in these isolates (Chantratita et al., 2016) . In contrast, in a second Thai study, ten patients (4.1%) were found to be infected with S. argenteus, three cases were associated with bacteremia and one patient died from this infection, however all three patients suffered from at least two underlying diseases (Thaipadungpanit et al., 2015) . Here, the genome sequence of S. argenteus strain BN75 which harbours even less virulence and resistance factors than S. argenteus MSHR1132 T indicates that this strain might be less virulent than the typical S. aureus isolate. In conclusion, further research on this new species is needed to address its virulence and, to this end, the correct species determination in the clinical laboratory, for example by MALDI-TOF MS as described here, is essential and should be implemented in routine laboratory diagnostics. 
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